Point Mutation Selective Photo-Cross-Linking Reactions by Diazirine-Derivatized ODNs

Kentaro Kobata1, Daiki Unita1, Kazuya Matsuo1

  • 1Faculty of Molecular Chemistry and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.

Insights

Researchers developed novel photo-cross-linking oligonucleotides (U-ODN) to target and inhibit mutated KRAS messenger RNAs (mRNAs). This new method shows promise for selectively targeting point mutations in genes like KRAS.

Area of Science:

  • Molecular Biology
  • Oligonucleotide Chemistry

Background:

  • KRAS gene mutations, primarily point mutations, are common in various cancers.
  • Targeting these specific mutations for therapeutic intervention remains a significant challenge in molecular biology.

Purpose of the Study:

  • To develop novel photo-cross-linking oligonucleotides (U-ODN) capable of selectively targeting and inhibiting KRAS point mutations.
  • To investigate the reactivity and specificity of these U-ODN against wild-type and mutated RNA sequences.

Main Methods:

  • Synthesis of novel photo-cross-linking oligonucleotides (U-ODN) incorporating a diazirine group on uridine derivatives.
  • Photo-cross-linking assays were performed using both wild-type and mutated RNA targets.

Main Results:

  • U-ODN demonstrated efficient and selective photo-cross-linking with mutated RNAs.
  • The reactivity was specific to mutated RNAs with cytidine, guanosine, or uridine at the position adjacent to the U-ODN binding site.

Conclusions:

  • U-ODN represents a promising tool for selectively inhibiting the activity of mRNAs containing point mutations.
  • This approach offers potential for developing targeted therapies against diseases driven by KRAS mutations.